Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin | Patent Number 06239124

US 06239124 NA
Application Number9230618
Publication Number-
Pendency2 years, 4 months, 2 days
Filled DateJan 28, 1999
Priority DateJul 29, 1997
Publication Date-
Expiration DateJul 29, 2017
Inventor/Applicants Armin Meinzer
Hendrik Schuurman
Barbara Haeberlin
Gerhard Zenke
ExaminesWEDDINGTON, KEVIN E
Art Unit1614
Technology Center1600
Assignments
Novartis
Current
Novartis
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.